Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

[1]  J. Stenvang,et al.  Progesterone Receptor Isoform Analysis by Quantitative Real-Time Polymerase Chain Reaction in Formalin-Fixed, Paraffin-Embedded Canine Mammary Dysplasias and Tumors , 2014, Veterinary pathology.

[2]  G. Rutteman,et al.  Progesterone receptor isoforms in the mammary gland of cats and dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[3]  M. Ohmichi,et al.  Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis , 2012, Journal of Ovarian Research.

[4]  A. Molinolo,et al.  Antiprogestins in breast cancer treatment: are we ready? , 2012, Endocrine-related cancer.

[5]  F. Gärtner,et al.  Canine tumors: a spontaneous animal model of human carcinogenesis. , 2012, Translational research : the journal of laboratory and clinical medicine.

[6]  E. Capp,et al.  Transvaginal ultrasound ovarian diathermy: sheep as an experimental model , 2012, Journal of Ovarian Research.

[7]  F. Guscetti,et al.  Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas. , 2011, Journal of veterinary internal medicine.

[8]  Sundeep Chandra,et al.  Cyclic Morphological Changes in the Beagle Mammary Gland , 2010, Toxicologic pathology.

[9]  K. Arihiro,et al.  Comparison of immunohistochemistry assays and real‐time reverse transcription–polymerase chain reaction for analyzing hormone receptor status in human breast carcinoma , 2010, Pathology international.

[10]  A. Molinolo,et al.  Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas , 2009, Breast Cancer Research and Treatment.

[11]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[12]  Y. Li,et al.  Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist , 2006, Science.

[13]  Y. Millán,et al.  A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor α and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog , 2005, Veterinary pathology.

[14]  A. Porter,et al.  Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells , 2004, Clinical Cancer Research.

[15]  G. Chenevix-Trench,et al.  Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A , 2004, Genes, chromosomes & cancer.

[16]  G. Rutteman,et al.  Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  E. Glattre,et al.  A population‐based case‐control study of canine mammary tumours and clinical use of medroxyprogesterone acetate , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  Gilmore Hr,et al.  Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.

[19]  Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium , 2001 .

[20]  W. Misdorp.  Histological classification of mammary tumors of the dog and the cat , 1999 .